Rhumbline Advisers BENITEC BIOPHARMA INC Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
Number of Shares
20,858
Previous 186
11113.98%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%